Tabone M - Search Results

1

Interferon and amantadine in combination as initial treatment for chronic hepatitis C patients.

Tabone M, Laudi C, Delmastro B, Biglino A, Andreoni M, Chieppa F, Bonardi R, Cariti G, Cusumano S, Brunello F, Calleri G, Manca A, Della Monica P, Sidoli L, Rizzetto M, Pera A. Tabone M, et al. J Hepatol. 2001 Oct;35(4):517-21. doi: 10.1016/s0168-8278(01)00166-0. J Hepatol. 2001. PMID: 11682037 Clinical Trial.

2

A randomized 4-arm multicenter study of interferon alfa-2b plus ribavirin in the treatment of patients with chronic hepatitis C relapsing after interferon monotherapy.

Saracco G, Olivero A, Ciancio A, Carenzi S, Smedile A, Cariti G, Andreoni M, Orsi PG, Biglino A, Tabone M, Roffi L, Croce G, Manca A, Tappero G, Ciccone G, Rizzetto M. Saracco G, et al. Among authors: tabone m. Hepatology. 2002 Oct;36(4 Pt 1):959-66. doi: 10.1053/jhep.2002.35442. Hepatology. 2002. PMID: 12297844 Clinical Trial.

3

Re-treatment with interferon-beta of patients with chronic hepatitis C virus infection.

Pellicano R, Palmas F, Cariti G, Tappero G, Boero M, Tabone M, Suriani R, Pontisso P, Pitaro M, Rizzetto M. Pellicano R, et al. Among authors: tabone m. Eur J Gastroenterol Hepatol. 2002 Dec;14(12):1377-82. doi: 10.1097/00042737-200212000-00015. Eur J Gastroenterol Hepatol. 2002. PMID: 12468961

4

Combination therapy with amantadine and interferon in naïve patients with chronic hepatitis C: meta-analysis of individual patient data from six clinical trials.

Mangia A, Leandro G, Helbling B, Renner EL, Tabone M, Sidoli L, Caronia S, Foster GR, Zeuzem S, Berg T, Di Marco V, Cino N, Andriulli A. Mangia A, et al. Among authors: tabone m. J Hepatol. 2004 Mar;40(3):478-83. doi: 10.1016/j.jhep.2003.11.002. J Hepatol. 2004. PMID: 15123363

5

Short duration treatment in genotype 1 chronic hepatitis C patients with rapid virologic response to pegylated interferon plus ribavirin.

Bonardi R, Tabone M, Manca A, Pellicano R, Ciancio A, Rizzetto M. Bonardi R, et al. Among authors: tabone m. Biomed Pharmacother. 2011 Jul;65(4):303-6. doi: 10.1016/j.biopha.2011.03.004. Epub 2011 May 30. Biomed Pharmacother. 2011. PMID: 21723079 Clinical Trial.

6

Pre-treatment levels of anti-HCV core IgM antibodies are closely associated with response to alpha interferon therapy in chronic hepatitis C patients.

Tabone M, Secreto P, Marini C, Bonardi R, Boero M, Taraglio S, Ercole E, Sallio Bruno F, Pera A. Tabone M, et al. Eur J Gastroenterol Hepatol. 1997 Mar;9(3):287-91. doi: 10.1097/00042737-199703000-00013. Eur J Gastroenterol Hepatol. 1997. PMID: 9096432

7

Amantadine hydrochloride decreases serum ALT activity without effects on serum HCV-RNA in chronic hepatitis C patients.

Tabone M, Ercole E, Zaffino C, Sallio Bruno F, Pera A, Bonino F. Tabone M, et al. Ital J Gastroenterol Hepatol. 1998 Dec;30(6):611-3. Ital J Gastroenterol Hepatol. 1998. PMID: 10076783 Clinical Trial.

8

Treatment with interferon-alpha2b of naive non-cirrhotic patients with chronic hepatitis C according to viraemia and genotype. Results of a randomized multicentre study. The North West Italian Hepatological Group.

Saracco G, Ciancio A, Ghisetti V, Rocca G, Cariti G, Andreoni M, Tabone M, Roffi L, Calleri G, Ballaré M, Terreni N, Sartori M, Tappero GF, Traverso A, Poggio A, Orani A, Maggi G, Di Napoli A, Arrigoni A, Rizzetto M; North West Italian Hepatological Group. Saracco G, et al. Among authors: tabone m. Eur J Gastroenterol Hepatol. 2001 Feb;13(2):149-55. doi: 10.1097/00042737-200102000-00010. Eur J Gastroenterol Hepatol. 2001. PMID: 11246614 Clinical Trial.

9

Alcohol abstinence does not offset the strong negative effect of lifetime alcohol consumption on the outcome of interferon therapy.

Tabone M, Sidoli L, Laudi C, Pellegrino S, Rocca G, Della Monica P, Fracchia M, Galatola G, Molinaro GC, Aricò S, Pera A. Tabone M, et al. J Viral Hepat. 2002 Jul;9(4):288-94. doi: 10.1046/j.1365-2893.2002.00360.x. J Viral Hepat. 2002. PMID: 12081606

10

A randomized trial of pegylated-interferon-alpha2a plus ribavirin with or without amantadine in the re-treatment of patients with chronic hepatitis C not responding to standard interferon and ribavirin.

Ciancio A, Picciotto A, Giordanino C, Smedile A, Tabone M, Manca A, Marenco G, Garbagnoli P, Andreoni M, Cariti G, Calleri G, Sartori M, Cusumano S, Grasso A, Rizzi R, Gallo M, Basso M, Anselmo M, Percario G, Ciccone G, Rizzetto M, Saracco G. Ciancio A, et al. Among authors: tabone m. Aliment Pharmacol Ther. 2006 Oct 1;24(7):1079-86. doi: 10.1111/j.1365-2036.2006.03098.x. Aliment Pharmacol Ther. 2006. PMID: 16984502 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

201 results

Search Page

Filters